Raymond James Financial Inc United Therapeutics Corp Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 51,744 shares of UTHR stock, worth $18 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
51,744Holding current value
$18 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
692Shares Held
60.6MCall Options Held
194KPut Options Held
298K-
Wealthfront Advisers LLC18.3MShares$6.37 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.9 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.53 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.1 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$994 Million15.42% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $15.8B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...